Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Early hair loss may indicate prostate issues.

Suppressing certain hormones might help prevent prostate cancer.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

α-spinasterol from Melandrium firmum can help reduce prostate enlargement.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Berberine may reduce prostate enlargement by blocking inflammation.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

A new compound was effective for imaging prostate cancer in rats.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Higher cholesterol levels increase aggressive prostate cancer risk.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Gene variation affects prostate issues and hair loss.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.